Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
出版年份 2020 全文链接
标题
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-23
DOI
10.1007/s13311-020-00926-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
- (2020) Pierre Branger et al. Neurotherapeutics
- ACC1 (Acetyl Coenzyme A Carboxylase 1) Is a Potential Immune Modulatory Target of Cerebral Ischemic Stroke
- (2019) Xin Wang et al. STROKE
- High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice
- (2019) Laura Couloume et al. Multiple Sclerosis Journal
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
- (2018) Jerry S. Wolinsky et al. ANNALS OF NEUROLOGY
- Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France
- (2018) Sandra Vukusic et al. Multiple Sclerosis Journal
- Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study
- (2017) Kathryn Stiede et al. HEPATOLOGY
- Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
- (2017) Daniel Ontaneda et al. LANCET
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
- (2016) J. Bonenfant et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- Structure and function of biotin-dependent carboxylases
- (2012) Liang Tong CELLULAR AND MOLECULAR LIFE SCIENCES
- Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
- (2012) Robert J Fox et al. Multiple Sclerosis Journal
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now